Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by DAVIES, E. J.
Right arrow Articles by GRENNAN, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DAVIES, E. J.
Right arrow Articles by GRENNAN, D. M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1993 British Society for Rheumatology

research-article

HLA-DQ, DR AND COMPLEMENT C4 VARIANTS IN SYSTEMIC LUPUS ERYTHEMATOSUS

E. J. DAVIES*, M. C. HILLARBY*, R. G. COOPER*, E. M. HAY{dagger}, J. R. GREEN{ddagger}, S. SHAH{ddagger}, R. M. BERNSTEIN{dagger}, P. J. L. HOLT{dagger} and D. M. GRENNAN

*University of Manchester Rheumatic Diseuses Centre, Hope Hospital Sulford
{dagger}University of Manchester Rheumatism Research Centre, Manchester Royal Infirmary
{ddagger}Department of Statistics and Computational Mathematics, University of Liverpool

We have defined HLA-DQA, DQB, DR and complement C4 variants in 92 subjects with SLE and 73 controls. Subjects with SLE showed an increased frequency of HLA-DQA*0501 (P<0.01 corrected, odds ratio (OR) = 4.97; 95% C.I. = 2.52–9.81), DR3 (P<0.001, OR = 3.18; 95% C.I. = 1.67–6.04) and C4A*QO (P<0.05, OR = 1.91; 95% C.I. = 0.999–3.65) vs controls. These increases were particularly marked in those subjects positive for antibodies to both Ro and La. HLA-DQB*0501 (P<0.01 corrected, OR = 0.03), DQA*0101 (P = 0.0012 uncorrected, OR = 0.23) and DR7 (P = 0.0018 uncorrected, OR = 0.28) were decreased in frequency in SLE. SLE patients with disease onset prior to age 30 yr were more likely to possess a DR3-bearing haplotype (P<0.05 corrected) than those with onset after age 30 yr. No significant associations were found in patients with circulating antibodies to double-stranded DNA, Ro alone, U1 RNP, Sm or in those SLE patients with renal disease or vasculitis. The different associations found in different clinical and immunological subsets of SLE support the concept that SLE contains a variety of immunogenetic subgroups.

Analysis of the associations between SLE and DR3, DQA*0501 and C4A*Q0 using the empirical logistic test suggests that the association of SLE with HLA-DQA*0501 is likely to be primary to the associations with both DR3 and C4A*QO (P<0.001). Our results therefore raise the possibility that genes within the HLA-DQ region may have a direct effect upon susceptibility to SLE.

KEY WORDS: MHC class II, MHC class III, Immunogenetics, Empirical logistic analysis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 LupusHome page
P.H. Schur
Review: Genetics of systemic lupus erythematosus
Lupus, December 1, 1995; 4(6): 425 - 437.
[PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.